Medicare Negotiated Drugs Can Face Immediate Generic, Biosimilar Substitution, CMS Proposal Confirms

 
• By Cathy Kelly
  
The policy aims to help promote generic, biosimilar uptake in Medicare Part D. (Shutterstock)

More from Medicare

More from North America